Emad Azmy

495 total citations
35 papers, 361 citations indexed

About

Emad Azmy is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Emad Azmy has authored 35 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 12 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Emad Azmy's work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Emad Azmy is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Emad Azmy collaborates with scholars based in Egypt, United States and India. Emad Azmy's co-authors include Salah Aref, Doaa M. Elghannam, Niveen Saudy, Noureldien H. E. Darwish, Dhruba J. Bharali, Mohamed Ebrahim, Osama Elbaz, Thangirala Sudha, Nahla Anber and Kavitha Godugu and has published in prestigious journals such as Molecules, Blood Cells Molecules and Diseases and Blood Coagulation & Fibrinolysis.

In The Last Decade

Emad Azmy

28 papers receiving 360 citations

Peers

Emad Azmy

HEMAT

GENET

ONCOL

IMMUN

Kamal Chamoun United States

Belén López‐Millán Spain

Shauna L. French Australia

Yusuke Kamihara Japan

Debbie Piktel United States

Shirin Azizidoost Iran

Gabriella Bianchino Italy

Mauricio Oyarzo United States

Georgios Nteliopoulos United Kingdom

Erin Paterson New Zealand

Kamal Chamoun United States

Emad Azmy

134 ×0.8

HEMAT

122 ×1.0

128 ×1.9

GENET

85 ×1.3

ONCOL

34 ×0.6

IMMUN

Citations per year, relative to Emad Azmy Emad Azmy (= 1×) peers Kamal Chamoun

Countries citing papers authored by Emad Azmy

Since Specialization

Citations

This map shows the geographic impact of Emad Azmy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emad Azmy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emad Azmy more than expected).

Fields of papers citing papers by Emad Azmy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emad Azmy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emad Azmy. The network helps show where Emad Azmy may publish in the future.

Co-authorship network of co-authors of Emad Azmy

This figure shows the co-authorship network connecting the top 25 collaborators of Emad Azmy. A scholar is included among the top collaborators of Emad Azmy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emad Azmy. Emad Azmy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shamaa, Sameh, et al.. (2024). MM-095 Safety and Efficacy of Dexamethasone for Prevention of Engraftment Syndrome in a Patient With Multiple Myeloma Undergoing ASCT: A Single-Center Experience. Clinical Lymphoma Myeloma & Leukemia. 24. S535–S536.

Azmy, Emad, et al.. (2024). MPN-316 Molecular Analysis Always Wins: A Case Report of Philadelphia Chromosome-Positive Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia. 24. S428–S428.

Aref, Salah, et al.. (2024). Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia. Journal of the Egyptian National Cancer Institute. 36(1). 5–5. 3 indexed citations

Azmy, Emad, et al.. (2020). Clinical Impact of Percentage of Natural Killer Cells and Natural Killer-Like T Cell Population in Acute Myeloid Leukemia. Journal of Hematology. 9(3). 62–70. 11 indexed citations

El‐Ashwah, Shaimaa, et al.. (2020). Low platelet to lymphocyte ratio and high platelet distribution width have an inferior outcome in chronic lymphocytic leukaemia patients. Nowotwory Journal of Oncology. 70(4). 121–126. 2 indexed citations

Darwish, Noureldien H. E., Thangirala Sudha, Kavitha Godugu, et al.. (2019). Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. Molecules. 24(11). 2103–2103. 55 indexed citations

Azmy, Emad, et al.. (2019). The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia. Hematology/Oncology and Stem Cell Therapy. 12(2). 97–104. 9 indexed citations

Negm, Nabel A., et al.. (2016). Production of Biodiesel Production from Castor Oil Using Modified Montmorillonite Clay. Egyptian Journal of Chemistry. 59(6). 1045–1060. 18 indexed citations

Azmy, Emad, et al.. (2016). Iron overload detection using pituitary and hepatic MRI in thalassemic patients having short stature and hypogonadism. Endocrine Research. 41(2). 81–88. 15 indexed citations

10.

Aref, Salah, et al.. (2014). Wilms Tumor 1 Gene Mutations in Patients with Cytogenetically Normal Acute Myeloid Leukemia. Turkish Journal of Hematology. 31(2). 143–148. 3 indexed citations

11.

Tawfik, Ahmed M., et al.. (2014). Diffusion-Weighted MR Imaging of the Benign Hepatic Focal Lesions. Open Journal of Radiology. 4(1). 136–143. 2 indexed citations

12.

Saudy, Niveen, et al.. (2014). BMI1 gene expression in myeloid leukemias and its impact on prognosis. Blood Cells Molecules and Diseases. 53(4). 194–198. 40 indexed citations

13.

Azmy, Emad, et al.. (2013). T-cell CD38 expression in B-chronic lymphocytic leukemia.

14.

Aref, Salah, et al.. (2013). Prognostic relevance of Wilms tumor 1 (WT1) gene Exon 7 mutations in-patient with cytogenetically normal acute myeloid leukemia. Indian Journal of Hematology and Blood Transfusion. 30(4). 226–230. 5 indexed citations

15.

Azmy, Emad, et al.. (2012). The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia. Blood Coagulation & Fibrinolysis. 23(4). 311–315. 27 indexed citations

16.

Razek, Ahmed Abdel Khalek Abdel, et al.. (2012). Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma. La radiologia medica. 118(5). 799–805. 16 indexed citations

17.

Azmy, Emad, et al.. (2011). Prognostic significance of FLT3 internal tandem duplication in Egyptian acute myeloid leukemia and normal cytogenetics. Comparative Clinical Pathology. 21(5). 1029–1035. 5 indexed citations

18.

Elghannam, Doaa M., et al.. (2009). Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.. PubMed. 16(1). 9–15. 3 indexed citations

19.

Azmy, Emad, et al.. (2009). T‐cell CD38 expression in B‐chronic lymphocytic leukaemia. Hematological Oncology. 27(2). 82–89. 8 indexed citations

20.

Aref, Salah, et al.. (2007). Prognostic relevance of circulating matrix metalloproteinase‐2 in acute myeloid leukaemia patients. Hematological Oncology. 25(3). 121–126. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact